GlassScriptPhysician profile
Ravi Shah
NPI 1295186872
$4,807.10
in general payments reported to CMS, 2019-2025
23 companies · $966 in 2025
The $966 reported for 2025 was more than what 76% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $921 · 2020: $91.65 · 2021: $182 · 2022: $338 · 2023: $930 · 2024: $1,378 · 2025: $966.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,274.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,274.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,154.36 | 2019-2025 | Clareon, Rocklatan, Argos |
| Bausch & Lomb Americas INC. | $588.16 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Abbvie INC. | $530.34 | 2022-2025 | Lumigan, Durysta, Alphagan P |
| Rxsight INC | $406.31 | 2023-2025 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Glaukos Corporation | $365.17 | 2022-2025 | Photrexa Viscous and Photrexa, Ce-Marked Kxla System, Kxl System (Not Refurbished) |
| Dompe US, INC. | $316.06 | 2022-2025 | Oxervate |
| Tarsus Pharmaceuticals, INC. | $216.24 | 2024-2025 | Xdemvy |
| Carl Zeiss Meditec USA, INC. | $190.36 | 2024 | Eq Workplace |
| Oyster Point Pharma, INC. | $187.91 | 2023 | Tyrvaya |
| Allergan, INC. | $124.99 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $124.99 | 2019 | |
| Harrow Eye, LLC | $123.86 | 2024 | Vevye |
| New World Medical,INC. | $99.38 | 2025 | Clearpath, Streamline, Ahmed Glaucoma Valve |
| Johnson & Johnson Surgical Vision, INC. | $88.16 | 2023-2025 | Tecnis Iol, Catalys System |
| Abbott Laboratories | $71.31 | 2023-2025 | Cardiomems, Perclose Prostyle |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $65.46 | 2023-2024 | |
| Mallinckrodt Hospital Products INC. | $24.70 | 2024 | Acthar |
| Amgen INC. | $24.38 | 2025 | Tepezza |
| Ani Pharmaceuticals, INC. | $24.27 | 2025 | Purified Cortrophin Gel |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $24.09 | 2020 | |
| Apellis Pharmaceuticals, INC. | $19.85 | 2021 | |
| Ocular Therapeutix, INC. | $18.98 | 2023 | Dextenza |
| Johnson & Johnson Vision Care, INC. | $17.77 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ravi Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.